Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Virtu Financial
VIRT
$5.04B
| $725K | ﹤0.01% |
38,363
+20,926
| +120% | +$402K |
|
1802
Monro
MNRO
$359M
| $723K | ﹤0.01% |
14,643
+7,859
| +116% | +$391K |
|
1803
Sterling Infrastructure
STRL
$16.8B
| $722K | ﹤0.01% |
19,068
+6,249
| +49% | +$228K |
|
|
NOVA
1804
DELISTED
Sunnova Energy
NOVA
| $721K | ﹤0.01% |
46,216
+19,559
| +73% | +$342K |
|
1805
Methode Electronics
MEI
$602M
| $720K | ﹤0.01% |
16,409
+8,793
| +115% | +$407K |
|
|
CPRX
1806
DELISTED
Catalyst Pharmaceutical
CPRX
| $720K | ﹤0.01% |
43,391
+23,375
| +117% | +$386K |
|
1807
Cohen & Steers
CNS
$4.36B
| $719K | ﹤0.01% |
11,251
+3,390
| +43% | +$236K |
|
1808
Green Brick Partners
GRBK
$3.02B
| $719K | ﹤0.01% |
20,507
+4,260
| +26% | +$132K |
|
1809
Central Garden & Pet Co Class A
CENTA
$2.43B
| $718K | ﹤0.01% |
22,971
+12,783
| +125% | +$393K |
|
|
MRTX
1810
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $716K | ﹤0.01% |
19,238
-508,471
| -96% | -$22.9M |
|
|
DSEY
1811
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $714K | ﹤0.01% |
88,304
+71,417
| +423% | +$453K |
|
|
GTM
1812
ZoomInfo Technologies
GTM
$1.12B
| $713K | ﹤0.01% |
28,890
-117,576
| -80% | -$3.02M |
|
1813
First Horizon
FHN
$12.3B
| $712K | ﹤0.01% |
40,023
+51
| +0.1% | +$1.13K |
|
|
LSXMK
1814
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $712K | ﹤0.01% |
32,824
+1,253
| +4% | +$33K |
|
|
APMI
1815
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
| $708K | ﹤0.01% |
+70,000
| New | +$703K |
|
1816
CAE Inc. Common Shares
CAE
$8.9B
| $708K | ﹤0.01% |
31,340
| – | – |
|
1817
NovoCure
NVCR
$2.05B
| $706K | ﹤0.01% |
11,744
-14,701
| -56% | -$1.17M |
|
1818
Q2 Holdings
QTWO
$3.9B
| $706K | ﹤0.01% |
28,691
+17,948
| +167% | +$534K |
|
|
JBGS
1819
JBG SMITH
JBGS
$691M
| $706K | ﹤0.01% |
46,893
+25,903
| +123% | +$459K |
|
1820
Krystal Biotech
KRYS
$9.85B
| $706K | ﹤0.01% |
8,811
+4,287
| +95% | +$337K |
|
1821
World Kinect Corp
WKC
$1.89B
| $706K | ﹤0.01% |
27,626
+14,859
| +116% | +$404K |
|
1822
Ironwood Pharmaceuticals
IRWD
$714M
| $706K | ﹤0.01% |
67,051
+43,245
| +182% | +$484K |
|
|
LAC
1823
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $705K | ﹤0.01% |
+32,381
| New | +$716K |
|
|
VSTO
1824
DELISTED
Vista Outdoor Inc.
VSTO
| $704K | ﹤0.01% |
25,398
+13,568
| +115% | +$371K |
|
1825
Cheesecake Factory
CAKE
$5.84B
| $703K | ﹤0.01% |
20,070
+11,190
| +126% | +$416K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.